ArticleBone marrow transplantation2010

CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.

D Jing et al.PubMed ↗Publisher ↗

No numbers read from the abstract.